MicroRNA-146a and hemopoietic disorders

International Journal of Hematology

Volumn 94, Issue 3, 2011, Pages 224-229

  Hua, Zhong ^a   Chun, Wang ^b   Fang yuan, Chen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Hematopoiesis disease; MiR 146a; Pathophysiological pathway

Indexed keywords

MESSENGER RNA; MICRORNA; SMAD4 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; BLOOD DISEASE; CANCER CELL CULTURE; CHROMOSOME 5Q; GENE DELETION; GENE SILENCING; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC SYSTEM; HETEROZYGOSITY; HUMAN; MONOCYTE; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW;

GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; HEMATOLOGIC DISEASES; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HUMANS; MICRORNAS; ONCOGENES;

EID: 80855123662     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0923-7     Document Type: Review

References (58)

1. Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nature Rev Genet. 2007;8(2): 93-103. (Pubitemid 46122839)
2. Bhagavathi S, Czader M. MicroRNAs in benign and malignant hematopoiesis. Arch Pathol Lab Med. 2010;134(9):1276-81.
3. Gangaraju VK, Lin H. MicroRNAs: Key regulators of stem cells. Nat Rev Mol Cell Biol. 2009;10:116-25.
4. Asli NS, Pitulescu ME, Kessel M. MicroRNAs in organogenesis and disease. Curr Mol Med. 2008;8:698-710.
5. Ambros V. The functions of animal microRNAs. Nature. 2004;431:350-5. (Pubitemid 39265675)
6. Yang B, Lin H, Xiao J, et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med. 2007;13:486-91. (Pubitemid 46559834)
7. Silvestri P, Di Russo C, Rigattieri S, et al. MicroRNAs and ischemic heart disease: Towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targets. Recent Pat Cardiovasc Drug Discov. 2009;4:109-18.
8. Care A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med. 2007;13:613-8. (Pubitemid 46828487)
9. Pedersen IM, Cheng G, Wieland S, et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature. 2007; 449:919-22. (Pubitemid 47598616)
10. Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004;432: 226-30. (Pubitemid 39545853)
11. Taganov KD, Boldin MP, Chang KJ, et al. NF-kappaB dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 2006;103:12481-6. (Pubitemid 44267285)
12. Tsitsiou E, Lindsay MA. MicroRNAs and the immune response. Curr Opin Pharmacol. 2009;9:514-20.
13. Perry MM, Moschos SA, Williams AE, et al. Rapid changes in microRNA-146a expression negatively regulate the IL-1betainduced inflammatory response in human lung alveolar epithelial cells. J Immunol. 2008;180:5689-98.
14. Lukiw WJ, Zhao Y, Cui JG. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem. 2008;283: 31315-22.
15. Williams AE, Perry MM, Moschos SA, et al. Role of miRNA- 146a in the regulation of the innate immune response and cancer. Biochem Soc Trans. 2008;36:1211-5.
16. Starczynowski DT, Kuchenbauer F, Wegrzyn J, et al. MicroRNA- 146a disrupts hematopoietic differentiation and survival. Exp Hematol. 2011;39(2):167-78.
17. Garzon R, Volinia S, Liu CG, et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood. 2008;111(6):3183-9.
18. Zhong H, Wang HR, Yang S, et al. Targeting Smad4 links microRNA-146a to the TGF-beta pathway during retinoid acid induction in acute promyelocytic leukemia cell line. Int J Hematol. 2010;92(1):129-35.
19. Monticelli S, Ansel KM, Xiao C, et al. MicroRNA profiling of the murine hematopoietic system. Genome Biol. 2005;6:R71.
20. Labbaye C, Spinello I, Quaranta MT, et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol. 2008;10:788-801. (Pubitemid 351927708)
21. Landry P, Plante I, Ouellet DL, et al. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol. 2009;16(9): 961-6.
22. Opalinska JB, Bersenev A, Zhang Z, et al. MicroRNA expression in maturing murine megakaryocytes. Blood. 2010;116(23): E128-38.
23. Pedersen I, David M. MicroRNAs in the immune response. Cytokine. 2008;43:391-4.
24. Cameron JE, Fewell C, Yin Q, et al. Epstein-Barr virus growth/ latency III program alters cellular microRNA expression. Virology. 2008;382:257-66.
25. Cameron JE, Yin Q, Fewell C, et al. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol. 2008;82:1946-58. (Pubitemid 351206940)
26. Nahid MA, Satoh M, Chan EK. Mechanistic role of microRNA- 146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol. 2011;186(3):1723-34.
27. Schmelzer C, Lorenz G, Rimbach G, et al. In vitro effects of the reduced form of coenzyme Q10 on secretion levels of TNF-a and chemokines in response to LPS in the human monocytic cell line THP-1. J Clin Biochem Nutr. 2009;44(1):62-6.
28. Suzuki Y, Kim HW, Ashraf M, et al. Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas. Am J Physiol Heart Circ Physiol. 2010;299(4):H1077-82.
29. Braun T, Carvalho G, Fabre C, et al. Targeting NF-kappaB in hematologic malignancies. Cell Death Differ. 2006;13:748-58.
30. Shen HM, Tergaonkar V. NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis. 2009;14:348-63.
31. Cilloni D, Martinelli G, Messa F, et al. Nuclear factor kB as a target for new drug development in myeloid malignancies. Haematologica. 2007;92:1224-9. (Pubitemid 350144181)
32. Braun T, Carvalho G, Coquelle A, et al. NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome. Blood. 2006;107:1156-65. (Pubitemid 43156318)
33. Zhao JL, Rao DS, Boldin MP, et al. NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. PNAS. 2011;108(22):9184-9.
34. Nakasa T, Miyaki S, Okubo A, et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2008; 58(5):1284-92. (Pubitemid 351705917)
35. Sheedy FJ, O'Neill LAJ. Adding fuel to fire: MicroRNAs as a new class of mediators of inflammation. Ann Rheumat Dis. 2008;67(s3):iii50-5.
36. Hou J, Wang P, Lin L, et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol. 2009;183(3): 2150-8.
37. Boldin MP, Taganov KD, Rao DS, et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med. 2011;208(6):1189-201.
38. Starczynowski DT, Kuchenbauer F, Argiropoulos B, et al. Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype. Nat Med. 2010;16:49-58.
39. Labbaye C, Spinello I, Quaranta MT, et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol. 2008;10(7):788-801. (Pubitemid 351927708)
40. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857-66. (Pubitemid 44629897)
41. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. PNAS. 2004;101(9):2999-3004. (Pubitemid 38327724)
42. Marcucci G, Mrózek K, Radmacher MD, et al. MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias. Best Pract Res Clin Haematol. 2009;22(2):239-48.
43. Dixon-McIver A, East P, Mein C, et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS ONE. 2008;3(5):e2141.
44. Jongen-Lavrencic M, Sun S, Dijkstra M, et al. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood. 2008;111:5078-85.
45. Li Z, Lu J, Sun M, et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. PNAS. 2008;105:15535-40.
46. Zhang H, Luo XQ, Zhang P, et al. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS ONE. 2009;4:e7826.
47. Wang Y, Li Z, He C, et al. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells Mol Dis. 2010;44:191-7.
48. Giagounidis AA, Germing U, Aul C. Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies. Clin Cancer Res. 2006;12(1):5-10. (Pubitemid 43166169)
49. Boultwood J, Fidler C, Strickson AJ, et al. Narrowing and genomic annotation of the commonly deleted region of the 5qsyndrome. Blood. 2002;99:4638-41. (Pubitemid 34627240)
50. Starczynowski DT, Morin R, McPherson A, et al. Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood. 2011;117(2):595-607.
51. Chen A, Luo M, Yuan G, et al. Complementary analysis of microRNA and mRNA expression during phorbol 12-myristate 13-acetate (TPA)-induced differentiation of HL-60 cells. Biotechnol Lett. 2008;30:2045-52.
52. Votavova H, Grmanova M, Merkerova MD, et al. Differential expression of microRNAs in CD34? cells of 5q-syndrome. J Hematol Oncol. 2011;4:1.
53. Visone R, Rassenti LZ, Veronese A, et al. Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood. 2009;114(18):3872-9.
54. Redondo-Munoz J, Escobar-Diaz E, Samaniego R, et al. MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration. Blood. 2006;108(9):3143-51.
55. Flamant S, Ritchie W, Guilhot J, et al. Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Hematologica. 2010;95(8):1325-33.
56. Lin HK, Chen Z, Wang G, et al. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature. 2010;464(7287):374-9.
57. Chang TC, Yu D, Lee YS, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008;40:43-50.
58. Paik JH, Jang JY, Jeon YK, et al. MicroRNA-146a downregulates NFkB activity via targeting TRAF6, and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin Cancer Res. 2011 (Epub ahead of print).